Cubist Systematic Strategies, LLC - RETROPHIN INC ownership

RETROPHIN INC's ticker is RTRX and the CUSIP is 761299106. A total of 134 filers reported holding RETROPHIN INC in Q3 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of RETROPHIN INC
ValueSharesWeighting
Q3 2020$582,000
-42.3%
31,516
-36.2%
0.01%
-47.1%
Q2 2020$1,008,000
+1552.5%
49,398
+1075.9%
0.02%
+750.0%
Q1 2020$61,000
-73.5%
4,201
-74.1%
0.00%
-50.0%
Q4 2019$230,000
-61.1%
16,224
-68.2%
0.00%
-66.7%
Q3 2019$591,000
-6.8%
50,970
+61.4%
0.01%0.0%
Q2 2019$634,000
-45.3%
31,571
-38.4%
0.01%
-68.4%
Q1 2019$1,160,000
+24.6%
51,238
+24.6%
0.04%
-13.6%
Q4 2018$931,000
+8363.6%
41,128
+10985.7%
0.04%
+4300.0%
Q3 2018$11,000
-98.4%
371
-98.5%
0.00%
-97.1%
Q2 2018$687,000
+408.9%
25,200
+318.0%
0.03%
+325.0%
Q1 2018$135,000
-54.2%
6,029
-56.9%
0.01%
-50.0%
Q4 2017$295,000
+293.3%
14,001
+367.6%
0.02%
+300.0%
Q3 2017$75,000
+127.3%
2,994
+77.6%
0.00%
+100.0%
Q2 2017$33,000
-34.0%
1,686
-37.9%
0.00%
-50.0%
Q1 2017$50,000
+47.1%
2,716
+51.7%
0.00%
+33.3%
Q4 2016$34,000
+78.9%
1,790
+106.2%
0.00%
+200.0%
Q3 2016$19,000
-74.0%
868
-75.8%
0.00%
-75.0%
Q3 2015$73,000
-24.7%
3,590
+23.0%
0.00%
-20.0%
Q2 2015$97,000
-80.8%
2,919
-86.1%
0.01%
-80.0%
Q1 2015$505,000
+12.2%
21,066
-42.7%
0.02%
+4.2%
Q4 2014$450,000
+1775.0%
36,762
+1666.6%
0.02%
+2300.0%
Q2 2014$24,0002,0810.00%
Other shareholders
RETROPHIN INC shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,693,371$82,584,0007.55%
Broadfin Capital, LLC 1,178,226$26,345,0004.10%
Tavio Capital LLC 293,923$6,572,0003.10%
SCOPIA CAPITAL MANAGEMENT LP 6,659,166$148,899,0002.98%
Perceptive Advisors 3,212,871$71,839,0002.01%
EMORY UNIVERSITY 115,136$2,574,0001.84%
Ghost Tree Capital, LLC 314,367$7,029,0001.42%
Virtus ETF Advisers LLC 41,803$935,0000.81%
SPHERA FUNDS MANAGEMENT LTD. 220,000$4,919,0000.75%
Telemetry Investments, L.L.C. 62,960$1,408,0000.53%
View complete list of RETROPHIN INC shareholders